14-Jan-2025
Oppenheimer Sticks to Their Buy Rating for Arcosa (ACA)
TipRanks (Tue, 14-Jan 8:26 AM ET)
Arcosa, Inc. Declares Quarterly Dividend and Renews $50 Million Share Repurchase Authorization
Business Wire (Thu, 12-Dec 4:15 PM ET)
Arcosa, Inc. Announces Third Quarter 2024 Results
Business Wire (Wed, 30-Oct 4:15 PM ET)
Arcosa, Inc. Announces Timing of Third Quarter 2024 Earnings Release and Conference Call
Business Wire (Tue, 15-Oct 4:16 PM ET)
Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.
Arcosa Common trades on the NYSE stock market under the symbol ACA.
As of January 14, 2025, ACA stock price climbed to $96.13 with 170,076 million shares trading.
ACA has a beta of 1.98, meaning it tends to be more sensitive to market movements. ACA has a correlation of 0.46 to the broad based SPY ETF.
ACA has a market cap of $4.69 billion. This is considered a Mid Cap stock.
Last quarter Arcosa Common reported $640 million in Revenue and $.91 earnings per share. This fell short of revenue expectation by $-42 million and exceeded earnings estimates by $.05.
In the last 3 years, ACA traded as high as $113.43 and as low as $43.42.
The top ETF exchange traded funds that ACA belongs to (by Net Assets): IJR, VTI, VB, IWM, VBR.
ACA has underperformed the market in the last year with a return of +22.0%, while SPY returned +23.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ACA shares. However, ACA has outperformed the market in the last 3 month and 2 week periods, returning +0.9% and -0.6%, while SPY returned 0.0% and -0.7%, respectively. This indicates ACA has been having a stronger performance recently.
ACA support price is $90.96 and resistance is $94.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACA shares will trade within this expected range on the day.